RECRUITING

Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).

Official Title

Continuous Glucose Monitor Use for Mayo Clinic Advanced Care at Home Patients With Diabetes Mellitus

Quick Facts

Study Start:2024-05-01
Study Completion:2025-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05880810

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who are admitted to Advanced Care at Home (ACH) Program and supposed to remain in ACH for at least 72 hours.
  2. * Patients with previous diagnosis of DM type 1 or type 2.
  3. * Patients taking subcutaneous (SQ) insulin either via multidose injections or SQ insulin pump.
  4. * Capable of giving signed informed consent
  1. * Actively treated for diabetes ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS).
  2. * Participants taking acetaminophen more than 4g per day or more than 1gm every 6 hours.
  3. * Participants with altered mental status.
  4. * Participants diagnosed with dementia.
  5. * Patients with suicidal ideations or experiencing suicidal behavior.
  6. * Patients with liver cirrhosis.
  7. * Patients with End Stage Renal Disease on dialysis bot hemodialysis or peritoneal dialysis.
  8. * Participants with allergy to medical grade adhesive or medical tape.
  9. * Participants taking hydroxyurea.
  10. * Participants who are pregnant, wanting to become pregnant, or nursing during study period.
  11. * Patients with a planned MRI within the following 10 days after admission to ACH.
  12. * Participants currently using continuous glucose monitor (CGM) to dose insulin or check glucose level.
  13. * Participants with diabetes mellitus (DM) treated with diet alone.
  14. * Participants with DM treated with oral hypoglycemic medications.
  15. * Participants with DM treated with one SQ insulin injection daily.
  16. * Participants enrolled in other studies addressing CGM use.
  17. * Participants physically or emotionally incapable of handling a cell phone with a smart display.
  18. * Participants with hearing impaired to a degree that they are not able to hear a smart phone alert or alarm.
  19. * Patients lacking WIFI or Cellular coverage needed to connect the monitoring cell phone to Internet network.

Contacts and Locations

Principal Investigator

Adrian Dumitrascu, MD
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Florida
Jacksonville, Florida, 32224
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Adrian Dumitrascu, MD, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-01
Study Completion Date2025-05

Study Record Updates

Study Start Date2024-05-01
Study Completion Date2025-05

Terms related to this study

Keywords Provided by Researchers

  • Advanced Care at Home Program (home hospital)

Additional Relevant MeSH Terms

  • Diabetes Mellitus